Form 4: Cerus COO Jayaraman Receives 420,000 RSU Grant
Insider Transaction Disclosure
Cerus Corporation's Chief Operating Officer, Vivek K. Jayaraman, was granted 420,000 Restricted Stock Units, aligning executive incentives with long-term shareholder value.
Summary
- Vivek K. Jayaraman, Chief Operating Officer of Cerus Corporation (CERS), reported the acquisition of 420,000 shares of common stock.
- This transaction, dated March 2, 2026, represents a grant of Restricted Stock Units (RSUs) at a price of $0 per share.
- The RSUs will vest in two annual installments: 34% on March 12, 2027, and 66% on March 12, 2028, contingent on continuous service to the Issuer.
- Following this transaction, Jayaraman beneficially owns 1,866,648 shares of common stock.
- The reported beneficial ownership also includes 5,318 shares purchased on August 29, 2025, and 10,004 shares purchased on February 27, 2026, under the Issuer's Employee Stock Purchase Plan.
- The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this RSU grant as a positive development, as it strengthens the alignment between executive incentives and long-term shareholder value, reflecting confidence in the company's future.
Positives
- The grant of 420,000 Restricted Stock Units (RSUs) to the Chief Operating Officer aligns executive compensation with long-term company performance and shareholder interests.
- Increased beneficial ownership for a key executive demonstrates continued commitment to the company's future.
- The vesting schedule incentivizes the COO's continuous service and contribution over the next two years.
Negatives
- The RSUs do not represent immediate cash compensation and are subject to a vesting schedule, meaning the shares are not fully owned until future dates.
- The value of the RSU grant is contingent on the future stock price of Cerus Corporation, introducing market risk.
Future Outlook
The vesting schedule for the Restricted Stock Units indicates an expectation of continued service from the Chief Operating Officer through March 2028, aligning executive incentives with the company's long-term strategic goals.
Industry Context
StockSavvy.ai notes that the grant of Restricted Stock Units is a common practice in executive compensation across the biotechnology and medical device industries. This approach aims to align the interests of key management with long-term shareholder value by tying a significant portion of compensation to the company's stock performance and the executive's continued tenure.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation Policy | The RSU grant was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), indicating a pre-arranged trading plan to avoid insider trading concerns. | 03/02/2026 | Enhances transparency and compliance with insider trading regulations, demonstrating sound corporate governance practices around executive equity compensation. |
Stakeholder Impact
- Shareholders: Potential for increased alignment of executive interests with long-term shareholder value, as the COO's compensation is tied to stock performance.
- Employees: May signal stability in executive leadership and a commitment to long-term growth, potentially boosting morale.
Next Steps
- Continued service of Vivek K. Jayaraman through the vesting periods.
- Vesting of 34% of RSUs on March 12, 2027.
- Vesting of 66% of RSUs on March 12, 2028.
Key Dates
| Date | Description |
|---|---|
| 08/29/2025 | Purchase of 5,318 shares under Issuer's Employee Stock Purchase Plan. |
| 02/27/2026 | Purchase of 10,004 shares under Issuer's Employee Stock Purchase Plan. |
| 03/02/2026 | Date of RSU grant transaction. |
| 03/04/2026 | Signature date of the Form 4 filing. |
| 03/12/2027 | First vesting date for 34% of the RSU grant. |
| 03/12/2028 | Second vesting date for 66% of the RSU grant. |
Keywords
Cerus Corporation, CERS, Restricted Stock Units, RSU Grant, Executive Compensation, Insider Transaction, Form 4, Vivek K. Jayaraman, Rule 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.